Cargando…
Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594563/ https://www.ncbi.nlm.nih.gov/pubmed/36270746 http://dx.doi.org/10.1136/rmdopen-2022-002525 |
| _version_ | 1784815450480181248 |
|---|---|
| author | Karonitsch, Thomas Yeghiazaryan, Lusine Lackner, Angelika Brezinsek, Hans Peter Stamm, Tanja A König, Franz Aletaha, Daniel Smolen, Josef S |
| author_facet | Karonitsch, Thomas Yeghiazaryan, Lusine Lackner, Angelika Brezinsek, Hans Peter Stamm, Tanja A König, Franz Aletaha, Daniel Smolen, Josef S |
| author_sort | Karonitsch, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9594563 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95945632022-10-26 Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature Karonitsch, Thomas Yeghiazaryan, Lusine Lackner, Angelika Brezinsek, Hans Peter Stamm, Tanja A König, Franz Aletaha, Daniel Smolen, Josef S RMD Open Rheumatoid Arthritis BMJ Publishing Group 2022-10-21 /pmc/articles/PMC9594563/ /pubmed/36270746 http://dx.doi.org/10.1136/rmdopen-2022-002525 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Rheumatoid Arthritis Karonitsch, Thomas Yeghiazaryan, Lusine Lackner, Angelika Brezinsek, Hans Peter Stamm, Tanja A König, Franz Aletaha, Daniel Smolen, Josef S Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title | Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title_full | Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title_fullStr | Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title_full_unstemmed | Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title_short | Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature |
| title_sort | targeting type i interferon (ifn) signalling in patients with ra with a high type i ifn gene signature |
| topic | Rheumatoid Arthritis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594563/ https://www.ncbi.nlm.nih.gov/pubmed/36270746 http://dx.doi.org/10.1136/rmdopen-2022-002525 |
| work_keys_str_mv | AT karonitschthomas targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT yeghiazaryanlusine targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT lacknerangelika targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT brezinsekhanspeter targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT stammtanjaa targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT konigfranz targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT aletahadaniel targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature AT smolenjosefs targetingtypeiinterferonifnsignallinginpatientswithrawithahightypeiifngenesignature |